Maria Chiara Gatto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria Chiara Gatto has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
Francesco Fedele
Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences of "Sapienza" University of Rome Rome Italy
4 shared publicationsAchille Gaspardone
2 shared publications- Alessandra Oliva
Sapienza University of Rome
2 shared publications Alessandro Persi
Ospedale San Camillo De Lellis Rieti Italy
2 shared publications- Amir Kol
Ospedale San Camillo de Lellis, 02100 Rieti, Italy
2 shared publications Carlo Lavalle
Department of Cardiovascular, Respiratory, Nephrological, Aenesthesiological and Geriatric Sciences, “Sapienza” University of Rome Policlinico Umberto I Rome Italy
2 shared publications
Latest Publications
- Open Access
- 15 August 2025
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 11 (11) , 1137-1139
First reported case of multielectrode mapping catheter delamination detected by intracardiac echocardiography during atrial fibrillation ablation
- 15 August 2025
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 11 (11) , 1137-1139
Open AccessFirst reported case of multielectrode mapping catheter delamination detected by intracardiac echocardiography during atrial fibrillation ablation
- Open Access
- 5 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (22) , 6630
Over-the-Wire Retrieval of Infectious Hemodialysis Catheter-Related Right Atrial Thrombus Causing Recurrent Pleural Empyema and Sepsis: A Case-Based Review
Introduction: Infectious catheter-related right atrial thrombus (CRAT) is a potentially fatal but often underestimated contingency associated with central venous catheter (CVC) in patients on hemodialysis. Management guidelines for CRAT are lacking, and its occurrence poses clinical challenges. Here, we describe the case of an infectious CRAT in a young patient on hemodialysis with peculiar clinical complications and perform a literature review. Case presentation and literature review: A 30-year-old man on hemodialysis after bilateral nephrectomy due to polycystic disease presented with hyperpyrexia resistant to broad-spectrum antibiotics. A pleural empyema caused by methicillin-resistant Staphylococcus aureus (MRSA) was diagnosed. Since fever persisted despite targeted antibiotic therapy, a transthoracic echocardiogram to exclude infective endocarditis was performed, showing a right atrial thrombus. CVC was promptly removed and the thrombus was aspirated through a percutaneous retrieval system. The thrombus cultural exam resulted positive for MRSA. After performing an extensive literature review, we could not find another case reporting the concomitance of these two rare complications. Conclusions: CRAT is a life-threatening complication in hemodialysis patients. While various treatment options exist, evidence-based guidelines are lacking, leading to individualized management strategies. Minimizing CVC use remains the best option for preventing such a complication.
- 5 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (22) , 6630
Open AccessOver-the-Wire Retrieval of Infectious Hemodialysis Catheter-Related Right Atrial Thrombus Causing Recurrent Pleural Empyema and Sepsis: A Case-Based Review
Introduction: Infectious catheter-related right atrial thrombus (CRAT) is a potentially fatal but often underestimated contingency associated with central venous catheter (CVC) in patients on hemodialysis. Management guidelines for CRAT are lacking, and its occurrence poses clinical challenges. Here, we describe the case of an infectious CRAT in a young patient on hemodialysis with peculiar clinical complications and perform a literature review. Case presentation and literature review: A 30-year-old man on hemodialysis after bilateral nephrectomy due to polycystic disease presented with hyperpyrexia resistant to broad-spectrum antibiotics. A pleural empyema caused by methicillin-resistant Staphylococcus aureus (MRSA) was diagnosed. Since fever persisted despite targeted antibiotic therapy, a transthoracic echocardiogram to exclude infective endocarditis was performed, showing a right atrial thrombus. CVC was promptly removed and the thrombus was aspirated through a percutaneous retrieval system. The thrombus cultural exam resulted positive for MRSA. After performing an extensive literature review, we could not find another case reporting the concomitance of these two rare complications. Conclusions: CRAT is a life-threatening complication in hemodialysis patients. While various treatment options exist, evidence-based guidelines are lacking, leading to individualized management strategies. Minimizing CVC use remains the best option for preventing such a complication.
- Open Access
- 2 July 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (7) , ytae315
Percutaneous retrieval of right intracardiac mass with Inari Flow-Triever System
The treatment of intracardiac masses is a complex clinical scenario. We describe two cases of right intracardiac masses with high embolic risk treated with a thrombo-aspiration system. The first case involves a 30-year-old male on dialysis for bilateral nephrectomy and previous percutaneous closure of an atrial septal defect, presenting with massive pleural empyema, methicillin-resistant Staphylococcus aureus bacteraemia, and a floating mass in the right atrium occupying the tricuspid orifice (Panel A and Supplementary material ). The second case involves a 72-year-old woman with single chamber pacemaker and diabetes, admitted after a head injury following a dizziness episode. During hospitalization, bilateral deep vein thrombosis, bilateral pulmonary embolism, and a thrombus in the right atrium adjacent to the pacemaker lead were detected ( Supplementary material ). In both cases, the floating thrombus-like masses were considered at high embolic risk and the patients underwent to emergency percutaneous thrombo-aspiration treatment.1–3 After few attempts, the clots were successfully removed in cath-lab using the Inari Flow-Triever System (Panel B and Supplementary material ). The first specimen had a cauliflower-like shape (Panel C) and resulted positive for methicillin-resistant S. aureus, therefore antibiotic therapy was optimized. The second specimen was a long red thrombus (Panel D), and the laboratory analysis was negative. The post-procedural course in both cases was free of complications, and both patients survived. The thrombo-aspiration systems have been designed for the removal of endovascular thrombotic formations and not specifically for the removal of endocavitary vegetations or masses. In particular, the Inari Flow-Triever System has been designed for rapid thrombus removal for patients with acute pulmonary embolism. However, our case demonstrates how it is technically feasible to aspirate atrial masses when the risk of embolization is very high. The successful management of these cases suggests the possibility that in emergency situations, the use of thrombo-aspiration systems can be useful in the removal of right intracardiac thrombotic masses.4
- 2 July 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (7) , ytae315
Open AccessPercutaneous retrieval of right intracardiac mass with Inari Flow-Triever System
The treatment of intracardiac masses is a complex clinical scenario. We describe two cases of right intracardiac masses with high embolic risk treated with a thrombo-aspiration system. The first case involves a 30-year-old male on dialysis for bilateral nephrectomy and previous percutaneous closure of an atrial septal defect, presenting with massive pleural empyema, methicillin-resistant Staphylococcus aureus bacteraemia, and a floating mass in the right atrium occupying the tricuspid orifice (Panel A and Supplementary material ). The second case involves a 72-year-old woman with single chamber pacemaker and diabetes, admitted after a head injury following a dizziness episode. During hospitalization, bilateral deep vein thrombosis, bilateral pulmonary embolism, and a thrombus in the right atrium adjacent to the pacemaker lead were detected ( Supplementary material ). In both cases, the floating thrombus-like masses were considered at high embolic risk and the patients underwent to emergency percutaneous thrombo-aspiration treatment.1–3 After few attempts, the clots were successfully removed in cath-lab using the Inari Flow-Triever System (Panel B and Supplementary material ). The first specimen had a cauliflower-like shape (Panel C) and resulted positive for methicillin-resistant S. aureus, therefore antibiotic therapy was optimized. The second specimen was a long red thrombus (Panel D), and the laboratory analysis was negative. The post-procedural course in both cases was free of complications, and both patients survived. The thrombo-aspiration systems have been designed for the removal of endovascular thrombotic formations and not specifically for the removal of endocavitary vegetations or masses. In particular, the Inari Flow-Triever System has been designed for rapid thrombus removal for patients with acute pulmonary embolism. However, our case demonstrates how it is technically feasible to aspirate atrial masses when the risk of embolization is very high. The successful management of these cases suggests the possibility that in emergency situations, the use of thrombo-aspiration systems can be useful in the removal of right intracardiac thrombotic masses.4
- Open Access
- 15 March 2024
- Published by MDPI AG in International Medical Education
- Vol. 3 (1) , 92-99
The Role of Health Institutions in Training Healthcare Personnel for the Digital Transition: The International Training Program of the Order of Physicians and Dentists of Rome
Digital health, encompassing the use of digital technologies in healthcare, and telemedicine, facilitating healthcare delivery across long distances, have witnessed widespread applications across various healthcare domains. The COVID-19 pandemic accelerated the adoption of digital solutions in healthcare, overcoming barriers to access and fostering transitions to new care models. However, healthcare professionals often lack digital health competencies, necessitating targeted training initiatives. This study presents a project initiated by the Order of Physicians and Dentists of Rome, promoting a comprehensive training program in digital health for healthcare professionals. This investigation aims to describe the project, report demographic characteristics of participants, and analyze survey results on participants’ perceptions of the training program. The Erasmus+ project, titled ‘Training of Physician Trainers in Telemedicine, eHealth, and Digital Medicine,’ facilitated the digital transition of the healthcare sector through international training. The project involved structured courses, job-shadowing, and support activities in Malta and Madrid. A survey, developed using the Delphi methodology, assessed participants’ views on telemedicine. Thirty participants, selected based on merit, engaged in the project. Survey responses highlighted a strong impact on participants’ understanding of digital health concepts and increased confidence in utilizing digital tools. Notably, 85% acknowledged significant skill acquisition in healthcare digitalization. The project addressed a critical training gap among healthcare professionals, emphasizing the need for ongoing education in digital health. Despite existing recommendations, formal digital health education remains limited. The study underscores the importance of educational efforts to foster a digitalized healthcare model.
- 15 March 2024
- Published by MDPI AG in International Medical Education
- Vol. 3 (1) , 92-99
Open AccessThe Role of Health Institutions in Training Healthcare Personnel for the Digital Transition: The International Training Program of the Order of Physicians and Dentists of Rome
Digital health, encompassing the use of digital technologies in healthcare, and telemedicine, facilitating healthcare delivery across long distances, have witnessed widespread applications across various healthcare domains. The COVID-19 pandemic accelerated the adoption of digital solutions in healthcare, overcoming barriers to access and fostering transitions to new care models. However, healthcare professionals often lack digital health competencies, necessitating targeted training initiatives. This study presents a project initiated by the Order of Physicians and Dentists of Rome, promoting a comprehensive training program in digital health for healthcare professionals. This investigation aims to describe the project, report demographic characteristics of participants, and analyze survey results on participants’ perceptions of the training program. The Erasmus+ project, titled ‘Training of Physician Trainers in Telemedicine, eHealth, and Digital Medicine,’ facilitated the digital transition of the healthcare sector through international training. The project involved structured courses, job-shadowing, and support activities in Malta and Madrid. A survey, developed using the Delphi methodology, assessed participants’ views on telemedicine. Thirty participants, selected based on merit, engaged in the project. Survey responses highlighted a strong impact on participants’ understanding of digital health concepts and increased confidence in utilizing digital tools. Notably, 85% acknowledged significant skill acquisition in healthcare digitalization. The project addressed a critical training gap among healthcare professionals, emphasizing the need for ongoing education in digital health. Despite existing recommendations, formal digital health education remains limited. The study underscores the importance of educational efforts to foster a digitalized healthcare model.
- Open Access
- 26 April 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (5) , 1282
Efficacy and Safety of Anticoagulant Therapy in COVID-19-Related Pulmonary Embolism with Different Extension
Pulmonary embolism (PE) has been associated with SARS-CoV-2 infection, and its incidence is highly variable. The aim of our study was to describe the radiological and clinical presentations, as well as the therapeutic management, of PEs that occurred during SARS-CoV-2 infection in a cohort of hospitalized patients. In this observational study, we enrolled patients with moderate COVID-19 who developed PE during hospitalization. Clinical, laboratory, and radiological features were recorded. PE was diagnosed on clinical suspicion and/or CT angiography. According to CT angiography results, two groups of patients were further distinguished: those with proximal or central pulmonary embolism (cPE) and those with distal or micro-pulmonary embolism (mPE). A total of 56 patients with a mean age of 78 ± 15 years were included. Overall, PE occurred after a median of 2 days from hospitalization (range 0–47 days) and, interestingly, the majority of them (89%) within the first 10 days of hospitalization, without differences between the groups. Patients with cPE were younger (p = 0.02), with a lower creatinine clearance (p = 0.04), and tended to have a higher body weight (p = 0.059) and higher D-Dimer values (p = 0.059) than patients with mPE. In all patients, low-weight molecular heparin (LWMH) at anticoagulant dosage was promptly started as soon as PE was diagnosed. After a mean of 16 ± 9 days, 94% of patients with cPE were switched to oral anticoagulant (OAC) therapy, which was a direct oral anticoagulant (DOAC) in 86% of cases. In contrast, only in 68% of patients with mPE, the prosecution with OAC was indicated. The duration of treatment was at least 3 months from PE diagnosis in all patients who started OAC. At the 3-month follow-up, no persistence or recurrence of PE as well as no clinically relevant bleedings were found in both groups. In conclusion, pulmonary embolism in patients with SARS-CoV-2 may have different extensions. Used with clinical judgment, oral anticoagulant therapy with DOAC was effective and safe.
- 26 April 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (5) , 1282
Open AccessEfficacy and Safety of Anticoagulant Therapy in COVID-19-Related Pulmonary Embolism with Different Extension
Pulmonary embolism (PE) has been associated with SARS-CoV-2 infection, and its incidence is highly variable. The aim of our study was to describe the radiological and clinical presentations, as well as the therapeutic management, of PEs that occurred during SARS-CoV-2 infection in a cohort of hospitalized patients. In this observational study, we enrolled patients with moderate COVID-19 who developed PE during hospitalization. Clinical, laboratory, and radiological features were recorded. PE was diagnosed on clinical suspicion and/or CT angiography. According to CT angiography results, two groups of patients were further distinguished: those with proximal or central pulmonary embolism (cPE) and those with distal or micro-pulmonary embolism (mPE). A total of 56 patients with a mean age of 78 ± 15 years were included. Overall, PE occurred after a median of 2 days from hospitalization (range 0–47 days) and, interestingly, the majority of them (89%) within the first 10 days of hospitalization, without differences between the groups. Patients with cPE were younger (p = 0.02), with a lower creatinine clearance (p = 0.04), and tended to have a higher body weight (p = 0.059) and higher D-Dimer values (p = 0.059) than patients with mPE. In all patients, low-weight molecular heparin (LWMH) at anticoagulant dosage was promptly started as soon as PE was diagnosed. After a mean of 16 ± 9 days, 94% of patients with cPE were switched to oral anticoagulant (OAC) therapy, which was a direct oral anticoagulant (DOAC) in 86% of cases. In contrast, only in 68% of patients with mPE, the prosecution with OAC was indicated. The duration of treatment was at least 3 months from PE diagnosis in all patients who started OAC. At the 3-month follow-up, no persistence or recurrence of PE as well as no clinically relevant bleedings were found in both groups. In conclusion, pulmonary embolism in patients with SARS-CoV-2 may have different extensions. Used with clinical judgment, oral anticoagulant therapy with DOAC was effective and safe.
- Open Access
- 30 April 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (9) , 2537
Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19
Background: Electrocardiogram (ECG) offers a valuable resource easily available in the emergency setting. Objective: Aim of the study was to describe ECG alterations on emergency department (ED) presentation or that developed during hospitalization in SARS-CoV-2-infected patients and their association with 28-day mortality. Methods: A retrospective, single-center study including hospitalized patients with SARS-CoV-2 was conducted. ECG was recorded on ED admission to determine: heart rhythm, rate, and cycle; atrio-ventricular and intra-ventricular conduction; right ventricular strain; and ventricular repolarization. A specialized cardiologist blinded for the outcomes performed all 12-lead ECG analyses and their interpretation. Results: 190 patients were included, with a total of 24 deaths (12.6%). Age (p < 0.0001) and comorbidity burden were significantly higher in non-survivors (p < 0.0001). Atrial fibrillation (AF) was more frequent in non-survivors (p < 0.0001), alongside a longer QTc interval (p = 0.0002), a lower Tp-e/QTc ratio (p = 0.0003), and right ventricular strain (p = 0.013). Remdesivir administration was associated with bradycardia development (p = 0.0005) but no increase in mortality rates. In a Cox regression model, AF (aHR 3.02 (95% CI 1.03–8.81); p = 0.042), QTc interval above 451 ms (aHR 3.24 (95% CI 1.09–9.62); p = 0.033), and right ventricular strain (aHR 2.94 (95% CI 1.01–8.55); p = 0.047) were associated with higher 28-day mortality risk. Conclusions: QTc interval > 451 ms, right ventricular strain, and AF are associated with higher mortality risk in SARS-CoV-2 hospitalized patients. ECG recording and its appropriate analysis offers a simple, quick, non-expensive, and validated approach in the emergency setting to guide COVID-19 patients’ stratification.
- 30 April 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (9) , 2537
Open AccessPrognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19
Background: Electrocardiogram (ECG) offers a valuable resource easily available in the emergency setting. Objective: Aim of the study was to describe ECG alterations on emergency department (ED) presentation or that developed during hospitalization in SARS-CoV-2-infected patients and their association with 28-day mortality. Methods: A retrospective, single-center study including hospitalized patients with SARS-CoV-2 was conducted. ECG was recorded on ED admission to determine: heart rhythm, rate, and cycle; atrio-ventricular and intra-ventricular conduction; right ventricular strain; and ventricular repolarization. A specialized cardiologist blinded for the outcomes performed all 12-lead ECG analyses and their interpretation. Results: 190 patients were included, with a total of 24 deaths (12.6%). Age (p < 0.0001) and comorbidity burden were significantly higher in non-survivors (p < 0.0001). Atrial fibrillation (AF) was more frequent in non-survivors (p < 0.0001), alongside a longer QTc interval (p = 0.0002), a lower Tp-e/QTc ratio (p = 0.0003), and right ventricular strain (p = 0.013). Remdesivir administration was associated with bradycardia development (p = 0.0005) but no increase in mortality rates. In a Cox regression model, AF (aHR 3.02 (95% CI 1.03–8.81); p = 0.042), QTc interval above 451 ms (aHR 3.24 (95% CI 1.09–9.62); p = 0.033), and right ventricular strain (aHR 2.94 (95% CI 1.01–8.55); p = 0.047) were associated with higher 28-day mortality risk. Conclusions: QTc interval > 451 ms, right ventricular strain, and AF are associated with higher mortality risk in SARS-CoV-2 hospitalized patients. ECG recording and its appropriate analysis offers a simple, quick, non-expensive, and validated approach in the emergency setting to guide COVID-19 patients’ stratification.
- Open Access
- 1 October 2021
- Published by Wiley in Journal of Arrhythmia
- Vol. 37 (5) , 1364-1367
Combined therapy with subcutaneous implantable cardiac defibrillator and leadless pacemaker in a patient with persistent left superior vena cava and mega coronary sinus: A challenging case for the best treatment
In a patient requiring pacing and defibrillation therapy, but without superior venous access, combined therapy with S-ICD and leadless pacemaker could be the best solution. An appropriate programming of both devices represents the technical challenge in order to avoid inappropriate shocks due to leadless pacing oversensing.
- 1 October 2021
- Published by Wiley in Journal of Arrhythmia
- Vol. 37 (5) , 1364-1367
Open AccessCombined therapy with subcutaneous implantable cardiac defibrillator and leadless pacemaker in a patient with persistent left superior vena cava and mega coronary sinus: A challenging case for the best treatment
In a patient requiring pacing and defibrillation therapy, but without superior venous access, combined therapy with S-ICD and leadless pacemaker could be the best solution. An appropriate programming of both devices represents the technical challenge in order to avoid inappropriate shocks due to leadless pacing oversensing.
- Open Access
- 14 July 2021
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 44 (9) , 1607-1615
Bradyarrhythmias in patients with SARS‐CoV‐2 infection: A narrative review and a clinical report
Several cardiovascular diseases and arrhythmic disorders have been described in COVID‐19 era as likely related to SARS‐CoV‐2 infection. The prognostic relevance of bradyarrhythmias during the infection has not been yet described and no data are available about long‐term heart conduction disorders. A review of literature concerning the association between hypokinetic arrhythmias and COVID‐19 from January 2020 to February 2021 was performed. The key‐words used for the research were: “sinus node disfunction,” “sick sinus syndrome (SSS),” “sino‐atrial block,” “atrio‐ventricular block (AVB),” “bradyarrhythmias,” and “COVID‐19″ or ”SARS‐CoV‐2.″ Excluding “relative bradycardia,” a total of 38 cases of bradyarrhythmia related to SARS‐CoV‐2 infection have been described, even in very young people, requiring in many cases a definitive pacemaker implantation. Furthermore, we report a case of non‐hospitalized 47‐years old man with a SSS developed as a consequence of mild SARS‐CoV‐2 infection. While in all described cases heart conduction disorders were found at presentation of the infection or during hospitalization for COVID‐19, in our case the diagnosis of SSS was made after the resolution of the infection. Although rarely, heart conduction disorders may occur during COVID‐19 and the present case highlights that a cardiological follow up may be desirable even after the resolution of infection, especially in the presence of symptoms suggesting a possible heart involvement.
- 14 July 2021
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 44 (9) , 1607-1615
Open AccessBradyarrhythmias in patients with SARS‐CoV‐2 infection: A narrative review and a clinical report
Several cardiovascular diseases and arrhythmic disorders have been described in COVID‐19 era as likely related to SARS‐CoV‐2 infection. The prognostic relevance of bradyarrhythmias during the infection has not been yet described and no data are available about long‐term heart conduction disorders. A review of literature concerning the association between hypokinetic arrhythmias and COVID‐19 from January 2020 to February 2021 was performed. The key‐words used for the research were: “sinus node disfunction,” “sick sinus syndrome (SSS),” “sino‐atrial block,” “atrio‐ventricular block (AVB),” “bradyarrhythmias,” and “COVID‐19″ or ”SARS‐CoV‐2.″ Excluding “relative bradycardia,” a total of 38 cases of bradyarrhythmia related to SARS‐CoV‐2 infection have been described, even in very young people, requiring in many cases a definitive pacemaker implantation. Furthermore, we report a case of non‐hospitalized 47‐years old man with a SSS developed as a consequence of mild SARS‐CoV‐2 infection. While in all described cases heart conduction disorders were found at presentation of the infection or during hospitalization for COVID‐19, in our case the diagnosis of SSS was made after the resolution of the infection. Although rarely, heart conduction disorders may occur during COVID‐19 and the present case highlights that a cardiological follow up may be desirable even after the resolution of infection, especially in the presence of symptoms suggesting a possible heart involvement.
- 1 July 2019
- Published by Wiley in Echocardiography
- Vol. 36 (8) , 1475-1481
2D/3D Echocardiographic features of patients with reverse remodeling after cardiac resynchronization therapy
Purpose: To describe clinical and echocardiographic characteristics associated with reverse left ventricular (LV) remodeling after 6 months of cardiac resynchronization therapy (CRT) in patients with nonischemic dilated cardiomyopathy.Methods: Twenty‐four consecutive patients underwent 2D and 3D echocardiography before and after 6 months of CRT implant. Several echocardiographic parameters including global longitudinal strain (GLS) and 3D mechanical dyssynchrony (MD) index were calculated. CRT response was defined as a decrease in LV end‐systolic volume (LVESV) of at least 10% at follow‐up. Patients were divided in two groups according to CRT response.Results: Cardiac resynchronization therapy responder (CRTR+) rate was 50%. Nonresponder (CRTR−) patients showed a less significant improvement in NYHA class at follow‐up. At baseline, CRTR− presented with higher LV end‐diastolic volume (LVEDV) (P = 0.031), LVESV (P = 0.024), lower left ventricular ejection fraction (LVEF) (P = 0.002) and less negative GLS (P = 0.03), and with higher diastolic dysfunction, more impaired right ventricle (RV), and higher pulmonary artery systolic pressure (PASP) (P = 0.002). No significant differences in echocardiographic parameters of MD were found. Univariate determinants of CRTR+ were LVEF (OR = 1.59, CI 95% = 1.13–2.22, P = 0.007) and TAPSE (OR 1.21, CI 95% = 1.024–1.429, P = 0.025). A ROC curve analysis showed a cutoff value of LVEF of 22.15% significantly related to CRTR+ (SE 80%, SP 50%).Conclusions: Our findings suggest that end‐stage HF patients, presenting before CRT with LVEF <22.15%, may not benefit from the procedure after 6 months. Mechanical dyssyncronicity did not provide additional information to improve candidate selection.
- 1 July 2019
- Published by Wiley in Echocardiography
- Vol. 36 (8) , 1475-1481
2D/3D Echocardiographic features of patients with reverse remodeling after cardiac resynchronization therapy
Purpose: To describe clinical and echocardiographic characteristics associated with reverse left ventricular (LV) remodeling after 6 months of cardiac resynchronization therapy (CRT) in patients with nonischemic dilated cardiomyopathy.Methods: Twenty‐four consecutive patients underwent 2D and 3D echocardiography before and after 6 months of CRT implant. Several echocardiographic parameters including global longitudinal strain (GLS) and 3D mechanical dyssynchrony (MD) index were calculated. CRT response was defined as a decrease in LV end‐systolic volume (LVESV) of at least 10% at follow‐up. Patients were divided in two groups according to CRT response.Results: Cardiac resynchronization therapy responder (CRTR+) rate was 50%. Nonresponder (CRTR−) patients showed a less significant improvement in NYHA class at follow‐up. At baseline, CRTR− presented with higher LV end‐diastolic volume (LVEDV) (P = 0.031), LVESV (P = 0.024), lower left ventricular ejection fraction (LVEF) (P = 0.002) and less negative GLS (P = 0.03), and with higher diastolic dysfunction, more impaired right ventricle (RV), and higher pulmonary artery systolic pressure (PASP) (P = 0.002). No significant differences in echocardiographic parameters of MD were found. Univariate determinants of CRTR+ were LVEF (OR = 1.59, CI 95% = 1.13–2.22, P = 0.007) and TAPSE (OR 1.21, CI 95% = 1.024–1.429, P = 0.025). A ROC curve analysis showed a cutoff value of LVEF of 22.15% significantly related to CRTR+ (SE 80%, SP 50%).Conclusions: Our findings suggest that end‐stage HF patients, presenting before CRT with LVEF <22.15%, may not benefit from the procedure after 6 months. Mechanical dyssyncronicity did not provide additional information to improve candidate selection.
- Open Access
- 9 January 2019
- Published by Wiley in Clinical Case Reports
- Vol. 7 (2) , 322-327
Delayed efficacy of radiofrequency catheter ablation on arrhythmias originating in the interventricular basal septum
Key Clinical Message: Delayed efficacy of radiofrequency energy can suppress ventricular arrhythmias after a failed ablation procedure. The implant of cardiac defibrillator for arrhythmia‐induced cardiomyopathy should be procrastinated after a period of follow‐up. Waiting for delayed efficacy is a reasonable choice to reduce the risk of complications associated with aggressive ablative approaches.
- 9 January 2019
- Published by Wiley in Clinical Case Reports
- Vol. 7 (2) , 322-327
Open AccessDelayed efficacy of radiofrequency catheter ablation on arrhythmias originating in the interventricular basal septum
Key Clinical Message: Delayed efficacy of radiofrequency energy can suppress ventricular arrhythmias after a failed ablation procedure. The implant of cardiac defibrillator for arrhythmia‐induced cardiomyopathy should be procrastinated after a period of follow‐up. Waiting for delayed efficacy is a reasonable choice to reduce the risk of complications associated with aggressive ablative approaches.